Clinical Trial Update: Combination Chemotherapy With or Without Dexrazoxane in Treating Children With Hodgkin's Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluated whether adding dexrazoxane to combination chemotherapy reduces cardiac toxicity in children with Hodgkin lymphoma. The trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hodgkin Lymphoma

Drugs mentioned

• DEXRAZOXANE (DEXRAZOXANE)

Snippet

Sponsor: Children's Oncology Group | Conditions: Cardiac Toxicity, Lymphoma | Phase 3 | Status: COMPLETED